Cargando…
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder that affects millions of people worldwide. AD pathogenesis is intricate. It primarily involves two main molecular players—amyloid-β (Aβ) and tau—which actually have an intrinsic trend to generate molecular assemblies that are tox...
Autores principales: | Catania, Marcella, Colombo, Laura, Sorrentino, Stefano, Cagnotto, Alfredo, Lucchetti, Jacopo, Barbagallo, Maria Chiara, Vannetiello, Ilaria, Vecchi, Elena Rita, Favagrossa, Monica, Costanza, Massimo, Giaccone, Giorgio, Salmona, Mario, Tagliavini, Fabrizio, Di Fede, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763104/ https://www.ncbi.nlm.nih.gov/pubmed/36028569 http://dx.doi.org/10.1038/s41380-022-01745-x |
Ejemplares similares
-
Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
por: Di Fede, Giuseppe, et al.
Publicado: (2016) -
Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
por: Catania, Marcella, et al.
Publicado: (2019) -
Translational Research in Alzheimer’s and Prion Diseases
por: Di Fede, Giuseppe, et al.
Publicado: (2018) -
Microglial Heterogeneity and Its Potential Role in Driving Phenotypic Diversity of Alzheimer’s Disease
por: Sorrentino, Stefano, et al.
Publicado: (2021) -
Molecular subtypes of Alzheimer’s disease
por: Di Fede, Giuseppe, et al.
Publicado: (2018)